CSIMarket
 
Bioaffinity Technologies Inc   (NASDAQ: BIAF)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $15.2700 $2.49 19.484%
Day's High: $20.349899291992188 Week Perf: 234.87 %
Day's Low: $ 10.90 30 Day Perf: 2781.13 %
Volume (M): 18,962,723 52 Wk High: $ 20.35
Volume (M$): $ 0 52 Wk Avg: $2.19
Open: $11.12 52 Wk Low: $0.32



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 0
 Employees 57
 Revenues (TTM) (Millions $) 6
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Business Description


Bioaffinity Technologies Inc. is a biotechnology company that focuses on the development and commercialization of innovative diagnostic tests. The company specializes in creating highly sensitive and specific tests for the early detection of various diseases, including cancer. Bioaffinity Technologies utilizes a proprietary technology called the Affinity Matrix, which allows for the detection of disease-specific biomarkers. This technology offers significant advantages over traditional diagnostic methods, such as improved accuracy and faster results. The company's goal is to improve patient outcomes by providing healthcare professionals with reliable and timely diagnostic tools.


   Company Address: 3300 Nacogdoches Road San Antonio 78217 TX
   Company Phone Number: 698-5334   Stock Exchange / Ticker: NASDAQ BIAF


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
FTRE   -5.9%    
GH   -0.06%    
NTRA        0.59% 
PSNL        0.76% 
SERA   -2.42%    
VCYT   -1.87%    
• View Complete Report
   



Stocks on the Move

Market Turmoil Hits BioAffinity Technologies Understanding the Recent Stock Sell-Off and Future Potential

Published Mon, Aug 5 2024 4:39 PM UTC

BioAffinity Technologies Inc (BIAF): Analyzing the Recent Sell-Off Amid Market ConcernsBioAffinity Technologies Inc (NASDAQ: BIAF) recently experienced a significant sell-off, leading to its shares now trading at $1.73. This is a stark contrast to its performance earlier in the year, where it had outperformed the market, supported by a series of favorable developments and a...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.90
Price to Sales (Expected) -
Price to Book 1.41
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.91
Working Capital Ratio 1.61
Leverage Ratio (MRQ) 1.02
Total Debt to Equity 0.02
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -120.15 $
Revenues (TTM) 16.93 $
Cash Flow (TTM) 6.59 $
Cash 6.97 $
Book Value 10.82 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 103,526
Net Income per Employee (TTM) -266,408
Receivable Turnover Ratio (TTM) 9.18
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.62

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -220.77 %
Net Margin (MRQ) -222.83 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Bioaffinity Technologies Inc's Segments
Department of Defense Observational Studies    0.07 % of total Revenue
Diagnostic Research and Development    0.07 % of total Revenue
Health Care Patient Service    31.37 % of total Revenue
Histology Service Fees    16.41 % of total Revenue
Medical Director Fees    1.19 % of total Revenue
Other Revenues    0.07 % of total Revenue
Laboratory Services    189.34 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.